<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39319016</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">0253-8253</ISSN><JournalIssue CitedMedium="Print"><Volume>2024</Volume><Issue>3</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Qatar medical journal</Title><ISOAbbreviation>Qatar Med J</ISOAbbreviation></Journal><ArticleTitle>Liver ultrasound evaluation of acutely increased liver function tests of COVID-19 hospitalized patients.</ArticleTitle><Pagination><StartPage>46</StartPage><MedlinePgn>46</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">46</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.5339/qmj.2024.46</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The incidence of hepatic abnormalities has been notably higher following the coronavirus disease 2019 (COVID-19) infection, attributed to the virus's entry into cells via angiotensin-converting enzyme 2 (ACE2) surface expression. The gastrointestinal tract's significant ACE2 expression, alongside a lesser degree in the biliary epithelium, has been implicated in gastrointestinal symptoms and liver injury.</AbstractText><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">The aim of this study was to determine whether specific ultrasonographic findings in the liver correlate with acute increases in liver function tests (LFTs) among hospitalized patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A retrospective analysis was conducted on hospitalized COVID-19 patients at Hazem Mebaireek General Hospital in Qatar, from March 1, 2020, to June 30, 2020. The study focused on patients who experienced acute increases in LFTs, excluding those with chronic liver disease. Ultrasound imaging and patient records were reviewed to gather data.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Out of 223 ultrasound studies of COVID-19 patients, 158 met the inclusion criteria. The majority were male, with a mean age of 47.76 ± 13.76 years. Ultrasound results showed 43.7% normal liver parenchyma, while 56.3% exhibited nonspecific abnormalities such as diffuse liver hyperechogenicity (39.2%), enlargement with diffuse hyperechogenicity (12.7%), and other findings (4.4%). The biliary tree was predominantly normal (96.2%), with 3.8% showing abnormalities, including intrahepatic (2.5%) and extrahepatic (1.3%) dilatation. Gallbladder evaluations were normal in 60.1% of cases, with 39.9% showing abnormalities like stones (6.3%), stones with sludge (13.3%), polyps (6.3%), wall thickening (1.9%), and other conditions (12%). A significant correlation was found between abnormal liver parenchyma findings and elevated levels of bilirubin (total and direct) and alkaline phosphatase, with p-values &lt; 0.05. Only aspartate aminotransferase levels showed a significant correlation with biliary tree abnormalities.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The most common ultrasonographic finding associated with acute increases in LFTs among hospitalized COVID-19 patients was diffuse liver hyperechogenicity, with or without enlargement. These findings suggest a nonspecific yet significant association with liver function anomalies in the context of COVID-19.</AbstractText><CopyrightInformation>© 2024 Almughalles, Khojaly, Nashwan, Darweesh, Licensee HBKU Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Almughalles</LastName><ForeName>Salah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hamad Medical Corporation, Doha, Qatar.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Imaging, Hamad Medical Corporation, Doha, Qatar *Email: salmughalles@hamad.qa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khojaly</LastName><ForeName>Shazaly N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Hamad Medical Corporation, Doha, Qatar.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Imaging, Hamad Medical Corporation, Doha, Qatar *Email: salmughalles@hamad.qa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nashwan</LastName><ForeName>Abdulqadir J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Hamad Medical Corporation, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darweesh</LastName><ForeName>Adham</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hamad Medical Corporation, Doha, Qatar.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Imaging, Hamad Medical Corporation, Doha, Qatar *Email: salmughalles@hamad.qa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Qatar</Country><MedlineTA>Qatar Med J</MedlineTA><NlmUniqueID>8101648</NlmUniqueID><ISSNLinking>0253-8253</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE2 expression</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">hepatic abnormalities</Keyword><Keyword MajorTopicYN="N">liver function tests</Keyword><Keyword MajorTopicYN="N">ultrasonography</Keyword></KeywordList><CoiStatement>No conflict of interest to declaire.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>4</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39319016</ArticleId><ArticleId IdType="pmc">PMC11420552</ArticleId><ArticleId IdType="doi">10.5339/qmj.2024.46</ArticleId><ArticleId IdType="pii">qmj.2024.46</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sidhwani SK, Mirza T, Khatoon A, Shaikh F, Khan R, Shaikh OA, et al. Inflammatory markers and COVID-19 disease progression. J Infect Public Health. 2023;;16((9):):1386-91. doi: 10.1016/j.jiph.2023.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2023.06.018</ArticleId><ArticleId IdType="pmc">PMC10290960</ArticleId><ArticleId IdType="pubmed">37442012</ArticleId></ArticleIdList></Reference><Reference><Citation>Safan AS, Imam Y, Khatib MY, Al Wraidat M, Altermanini MM, Al-Mughalles SA, et al. COVID-19-associated neurological sequelae: A case series on cerebral microbleeds and encephalopathy. Qatar Med J. 2023;;2023((4):):29. doi: 10.5339/qmj.2023.29.</Citation><ArticleIdList><ArticleId IdType="doi">10.5339/qmj.2023.29</ArticleId><ArticleId IdType="pmc">PMC10618109</ArticleId><ArticleId IdType="pubmed">37920783</ArticleId></ArticleIdList></Reference><Reference><Citation>Anjum MR, Chalmers J, Hamid R, Rajoriya N. COVID-19: Effect on gastroenterology and hepatology service provision and training: Lessons learnt and planning for the future. World J Gastroenterol. 2021;;27((44):):7625-48. doi: 10.3748/wjg.v27.i44.7625.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v27.i44.7625</ArticleId><ArticleId IdType="pmc">PMC8641058</ArticleId><ArticleId IdType="pubmed">34908803</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah MD, Sumeh AS, Sheraz M, Kavitha MS, Venmathi Maran BA, Rodrigues KF. A mini-review on the impact of COVID 19 on vital organs. Biomed Pharmacother. 2021;;143::112158. doi: 10.1016/j.biopha.2021.112158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.112158</ArticleId><ArticleId IdType="pmc">PMC8416601</ArticleId><ArticleId IdType="pubmed">34507116</ArticleId></ArticleIdList></Reference><Reference><Citation>Rismanbaf A, Zarei S. Liver and kidney injuries in COVID-19 and their effects on drug therapy; a letter to editor. Arch Acad Emerg Med. 2020;;8((1):):e17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7075271</ArticleId><ArticleId IdType="pubmed">32185369</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Shi L, Wang FS. Liver injury in COVID-19: Management and challenges. Lancet Gastroenterol Hepatol. 2020;;5((5):):428-30. doi: 10.1016/S2468-1253(20)30057-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(20)30057-1</ArticleId><ArticleId IdType="pmc">PMC7129165</ArticleId><ArticleId IdType="pubmed">32145190</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutherland F, Harris J. Claude Couinaud: A passion for the liver. Arch Surg. 2002;;137((11):):1305-10. doi: 10.1001/archsurg.137.11.1305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.137.11.1305</ArticleId><ArticleId IdType="pubmed">12413326</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai X, Hu L, Zhang Y, Han W, Lu Z, Ke A, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv. 2020 doi: 10.1101/2020.02.03.931766.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.02.03.931766</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;;158((6):):1831-3.e3. doi: 10.1053/j.gastro.2020.02.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.02.055</ArticleId><ArticleId IdType="pmc">PMC7130181</ArticleId><ArticleId IdType="pubmed">32142773</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G, He X, Zhang L, Ran Q, Wang J, Xiong A, et al. Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19. J Autoimmun. 2020;;112:(112:):102463. doi: 10.1016/j.jaut.2020.102463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2020.102463</ArticleId><ArticleId IdType="pmc">PMC7152872</ArticleId><ArticleId IdType="pubmed">32303424</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidhwani SK, Mirza T, Khatoon A, Shaikh F, Khan R, Shaikh OA, et al. Angiotensin-converting enzyme 2 (ACE2) polymorphisms and susceptibility of severe SARS-CoV-2 in a subset of Pakistani population. Virol J. 2023;;20((1):):120. doi: 10.1186/s12985-023-02091-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-023-02091-2</ArticleId><ArticleId IdType="pmc">PMC10258755</ArticleId><ArticleId IdType="pubmed">37308887</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;;395((10223):):507-13. doi: 10.1016/S0140-6736(20)30211-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan J, Xie W, Ou WN, Zhao H, Wang SY, Wang JH, et al. Epidemiological survey and risk factor analysis of fatty liver disease of adult residents, Beijing, China. J Gastroenterol Hepatol. 2013;;28((10):):1654-9. doi: 10.1111/jgh.12290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgh.12290</ArticleId><ArticleId IdType="pubmed">23731053</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo H, Zhang Z, Zhang Y, Liu Y, Wang J, Qian Z, et al. Analysis of liver injury factors in 332 patients with COVID-19 in Shanghai, China. Aging (Albany NY) 2020;;12((19):):18844-52. doi: 10.18632/aging.103860.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103860</ArticleId><ArticleId IdType="pmc">PMC7732320</ArticleId><ArticleId IdType="pubmed">33001040</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F, Chen W, Chen J, Xu D, Xie W, Wang X, et al. Clinical features and risk factors of COVID-19-associated liver injury and function: A retrospective analysis of 830 cases. Ann Hepatol. 2021;;21::100267. doi: 10.1016/j.aohep.2020.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aohep.2020.09.011</ArticleId><ArticleId IdType="pmc">PMC7548062</ArticleId><ArticleId IdType="pubmed">33053426</ArticleId></ArticleIdList></Reference><Reference><Citation>Zampino R, Mele F, Florio LL, Bertolino L, Andini R, Galdo M, et al. Liver injury in remdesivir-treated COVID-19 patients. Hepatol Int. 2020;;14((5):):881-3. doi: 10.1007/s12072-020-10077-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12072-020-10077-3</ArticleId><ArticleId IdType="pmc">PMC7386240</ArticleId><ArticleId IdType="pubmed">32725454</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelmohsen MA, Alkandari BM, Gupta VK, ElBeheiry AA. Diagnostic value of abdominal sonography in confirmed COVID-19 intensive care patients. Egypt J Radiol Nuclear Med. 2020;;51::198. doi: 10.1186/s43055-020-00317-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43055-020-00317-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Ippolito D, Maino C, Vernuccio F, Cannella R, Inchingolo R, Dezio M, et al. Liver involvement in patients with COVID-19 infection: A comprehensive overview of diagnostic imaging features. World J Gastroenterol. 2023;;29((5):):834-50. doi: 10.3748/wjg.v29.i5.834.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v29.i5.834</ArticleId><ArticleId IdType="pmc">PMC9932422</ArticleId><ArticleId IdType="pubmed">36816623</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhayana R, Som A, Li MD, Carey DE, Anderson MA, Blake MA, et al. Abdominal imaging findings in COVID-19: Preliminary observations. Radiology. 2020;;297((1):):E207-15. doi: 10.1148/radiol.2020201908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020201908</ArticleId><ArticleId IdType="pmc">PMC7508000</ArticleId><ArticleId IdType="pubmed">32391742</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji D, Qin E, Xu J, Zhang D, Cheng G, Wang Y, et al. Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study. J Hepatol. 2020;;73((2):):451-3. doi: 10.1016/j.jhep.2020.03.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.03.044</ArticleId><ArticleId IdType="pmc">PMC7141624</ArticleId><ArticleId IdType="pubmed">32278005</ArticleId></ArticleIdList></Reference><Reference><Citation>Spogis J, Hagen F, Thaiss WM, Hoffmann T, Malek N, Nikolaou K, et al. Sonographic findings in coronavirus disease-19 associated liver damage. PLoS One. 2021;;16((2):):e0244781. doi: 10.1371/journal.pone.0244781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0244781</ArticleId><ArticleId IdType="pmc">PMC7894893</ArticleId><ArticleId IdType="pubmed">33606703</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Q, Huang D, Yu H, Zhu Z, Xia Z, Su Y, et al. COVID-19: Abnormal liver function tests. J Hepatol. 2020;;73((3):):566-74. doi: 10.1016/j.jhep.2020.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.04.006</ArticleId><ArticleId IdType="pmc">PMC7194951</ArticleId><ArticleId IdType="pubmed">32298767</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>